Atanas Ignatov

19PUBLICATIONS
29CO-AUTHORS
Molecular targetsHaematological tumoursPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Radiation therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (19)

|May 28, 2025
GANNET53 Part II: A European Phase I/II Trial of the HSP90 Inhibitor Ganetespib in High-Grade Platinum-Resistant Ovarian Cancer-A Study of the GANNET53 Consortium.

Nicole Concin, Ioana Braicu, Pierre Combe

|Feb 07, 2025
Clinical characteristics, metastasis patterns, and treatment outcomes of HER2-low breast cancer.

Maria Elena Lacruz, Saskia Thies, Andrea Schmidt-Pokrzywniak

|Oct 16, 2024
Prognostic Impact of HER2 Low Status in Male Breast Cancer: Prospective Cohort Analysis.

Atanas Ignatov, Sina Lempfer, József Mészáros

|Dec 23, 2023
Oncologic Outcome of Robotic-Assisted and Laparoscopic Sentinel Node Biopsy in Endometrial Cancer.

Atanas Ignatov, József Mészáros, Stylianos Ivros

|Apr 03, 2021
Contralateral lymph node metastases in patients with vulvar cancer and unilateral sentinel lymph node metastases.

Tanja Ignatov, Johannes Gaßner, Mihaela Bozukova

|Mar 15, 2021
Adjuvant chemotherapy for breast cancer patients with axillary lymph node micrometastases.

Madeleine Hetterich, Michael Gerken, Olaf Ortmann

Pageof 4